Washington, DC – The American Pharmacists Association (APhA) appreciates the collaborative support announced by the Drug Enforcement Administration (DEA), the U.S. Department of Health and Human Services (HHS), and Substance Abuse and Mental Health Services Administration (SAMHSA) to break down access barriers to medications for opioid use disorder (MOUD).